Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages episode artwork

EPISODE · Oct 9, 2025 · 32 MIN

Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

from touchPODCAST · host touchpodcast

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC. The expert: Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com

Episode metadata supplied by the publisher feed · Published Oct 9, 2025

Embed this episode

Ready to play

Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

0:00 32:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 32 minutes long.

When was this touchPODCAST episode published?

This episode was published on October 9, 2025.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!